1. Financial Results Approval

The Board considered and approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026. The financial results were audited by KKC & Associates LLP who issued unmodified audit opinions.

Standalone Financial Highlights (₹ in crores):

  • Q4 FY26 Revenue: ₹29.23
  • Q4 FY26 Net Profit: ₹0.26
  • FY26 Revenue: ₹236.91
  • FY26 Net Profit: ₹72.51
  • Paid-up equity share capital: ₹14.14 crores (Face value ₹2 per share)
  • Q4 Basic EPS: ₹0.04; FY26 Basic EPS: ₹10.26

Consolidated Financial Highlights (₹ in crores):

  • Q4 FY26 Revenue: ₹29.27
  • Q4 FY26 Net Profit: ₹0.25
  • FY26 Revenue: ₹237.11
  • FY26 Net Profit: ₹72.69
  • Paid-up equity share capital: ₹14.14 crores (Face value ₹2 per share)
  • Q4 Basic EPS: ₹0.04; FY26 Basic EPS: ₹10.28

The consolidated results include subsidiaries: DAM Capital (USA) Inc, DAM Asset Management Limited, and IDFC Securities Singapore Pte Ltd (liquidated November 16, 2021).

2. Dividend Declaration

The Board recommended a Final Dividend of ₹1 per equity share (face value ₹2 each) for FY2025-26. The dividend is subject to shareholder approval at the ensuing Annual General Meeting and will be paid within 30 days from declaration. The Record Date will be communicated separately.

3. ESOP Scheme Amendment

Based on Nomination and Remuneration Committee recommendation, the Board ratified and approved amendments to the existing Pre-IPO ESOP Scheme ("DAM Capital Employee Stock Option Scheme 2024"), subject to shareholders' approval.

ESOP Scheme Details:

  • Total options: 35,34,300
  • Outstanding options as of March 31, 2026: 3,83,145 (from initial grant of 5,30,145, with 1,47,000 forfeited)
  • Options yet to be granted: 31,51,155
  • Exercise price: Up to 25% discount to market price at grant date, but not less than face value
  • Vesting period: Minimum 1 year, maximum 5 years from grant date
  • Exercise period: Maximum 6 years from each vesting date

4. Management Re-appointment

Based on Nomination and Remuneration Committee recommendation, the Board approved the re-appointment of Mr. Dharmesh Anil Mehta (DIN: 06734366) as Managing Director and Chief Executive Officer for 5 years effective June 10, 2026, subject to shareholder approval. It was confirmed that he is not debarred from holding director office by any SEBI order.

5. Management Change

Mr. Jateen Doshi, Whole Time Director (DIN: 08476768), completed his tenure on June 9, 2026 and did not seek re-appointment. He will continue as Head of Institutional Equities and Business Development in a mentoring capacity. He ceased to be Director and Key Managerial Personnel effective close of business hours on June 9, 2026, subject to requisite approvals.

6. Internal Auditor Appointment

Based on Audit Committee recommendation, the Board approved appointment of PricewaterhouseCoopers Services LLP (PwC) (LLPIN: AAI-8885) as Internal Auditor for FY2026-27 under Section 138 of Companies Act, 2013.

Additional Information

The company was listed on NSE and BSE on December 27, 2024. The Board approved a share split in July 2024 where each equity share of ₹10 was split into 5 equity shares of ₹2 each. The company recognized ₹0.63 crores as past service cost for gratuity due to implementation of new labor codes effective November 21, 2025.